Suchergebnisse

PubPharm (9)

1

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients : the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study

enthalten in: Cerebrovascular diseases | April 16, 2009

von Bousser, M. | Amarenco, P. | Chamorro, A. | +6

2

TIMP-2 gene polymorphism is associated with intracerebral hemorrhage

enthalten in: Cerebrovascular diseases | October 16, 2009

von Reuter, B. | Bugert, P. | Stroick, M. | +4

3

Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes : the LADIS (Leukoaraiosis and Disability in the Elderly) Study

enthalten in: Cerebrovascular diseases | February 14, 2006

von Basile, A. | Pantoni, L. | Pracucci, G. | +13

4

Impaired washout - embolism and ischemic stroke : further examples and proof of concept

enthalten in: Cerebrovascular diseases | May 17, 2005

von Sedlaczek, O. | Caplan, L. | Hennerici, M.

5

Early motor evoked potentials in acute stroke : adjunctive measure to MRI for assessment of prognosis in acute stroke within 6 hours

enthalten in: Cerebrovascular diseases | June 23, 2004

von Wöhrle, J. | Behrens, S. | Mielke, O. | +1

6

Stroke-like presentation in a case of Creutzfeldt-Jakob disease

enthalten in: Cerebrovascular diseases | August 6, 2004

von Szabo, K. | Achtnichts, L. | Grips, E. | +4

7

Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study

enthalten in: Cerebrovascular diseases | September 19, 2003

von Amarenco, P. | Bogousslavsky, J. | Callahan, A. | +5

8

Epidural hematoma and hemorrhagic infarction mimicking a left temporal meningioma

enthalten in: Cerebrovascular diseases | [1999]

Stroke vignette

von Schwartz, A. | Gass, A. | Hennerici, M.

9

Stroke treatment guided by transcranial Doppler monitoring in a patient unresponsive to standard regimens

enthalten in: Cerebrovascular diseases | April 23, 1999

von Behrens, S. | Daffertshofer, M. | Hennerici, M.

1
[1]